Glenview Trust’s Lam Research LRCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $43.4M | Buy |
100,253
+1,993
| +2% | +$605K | 0.6% | 38 |
|
|
2026
Q1 | $21M | Sell |
98,260
-292
| -0.3% | -$65.3K | 0.33% | 64 |
|
|
2025
Q4 | $16.9M | Buy |
98,552
+318
| +0.3% | +$49.5K | 0.26% | 79 |
|
|
2025
Q3 | $13.2M | Buy |
98,234
+667
| +0.7% | +$70.6K | 0.21% | 96 |
|
|
2025
Q2 | $9.5M | Buy |
97,567
+10,256
| +12% | +$813K | 0.16% | 118 |
|
|
2025
Q1 | $6.35M | Buy |
+87,311
| New | +$6.88M | 0.12% | 126 |
|
|
2024
Q4 | – | Sell |
-89,290
| Closed | -$7.29M | – | 493 |
|
|
2024
Q3 | $7.29M | Buy |
89,290
+12,690
| +17% | +$1.1M | 0.14% | 117 |
|
|
2024
Q2 | $8.16M | Buy |
76,600
+4,870
| +7% | +$467K | 0.16% | 108 |
|
|
2024
Q1 | $6.97M | Buy |
71,730
+16,210
| +29% | +$1.43M | 0.15% | 117 |
|
|
2023
Q4 | $4.35M | Buy |
55,520
+14,010
| +34% | +$955K | 0.11% | 134 |
|
|
2023
Q3 | $2.6M | Buy |
41,510
+11,940
| +40% | +$784K | 0.07% | 155 |
|
|
2023
Q2 | $1.9M | Buy |
29,570
+5,760
| +24% | +$325K | 0.05% | 177 |
|
|
2023
Q1 | $1.26M | Sell |
23,810
-230
| -1% | -$11.3K | 0.04% | 208 |
|
|
2022
Q4 | $1.01M | Buy |
24,040
+2,100
| +10% | +$87.8K | 0.03% | 218 |
|
|
2022
Q3 | $803K | Buy |
21,940
+1,700
| +8% | +$75.7K | 0.03% | 220 |
|
|
2022
Q2 | $863K | Buy |
20,240
+120
| +0.6% | +$5.71K | 0.03% | 217 |
|
|
2022
Q1 | $1.08M | Hold |
20,120
| – | – | 0.04% | 204 |
|
|
2021
Q4 | $1.45M | Hold |
20,120
| – | – | 0.05% | 180 |
|
|
2021
Q3 | $1.15M | Buy |
20,120
+730
| +4% | +$44.4K | 0.04% | 184 |
|
|
2021
Q2 | $1.26M | Sell |
19,390
-400
| -2% | -$25.3K | 0.05% | 174 |
|
|
2021
Q1 | $1.18M | Buy |
19,790
+10,390
| +111% | +$566K | 0.05% | 177 |
|
|
2020
Q4 | $444K | Hold |
9,400
| – | – | 0.02% | 247 |
|
|
2020
Q3 | $312K | Sell |
9,400
-3,510
| -27% | -$121K | 0.02% | 274 |
|
|
2020
Q2 | $418K | Sell |
12,910
-30
| -0.2% | -$818 | 0.02% | 245 |
|
|
2020
Q1 | $311K | Sell |
12,940
-110
| -0.8% | -$3.17K | 0.02% | 260 |
|
|
2019
Q4 | $382K | Hold |
13,050
| – | – | 0.02% | 269 |
|
|
2019
Q3 | $302K | Hold |
13,050
| – | – | 0.02% | 291 |
|
|
2019
Q2 | $245K | Buy |
13,050
+1,650
| +14% | +$31.3K | 0.02% | 304 |
|
|
2019
Q1 | $204K | Buy |
+11,400
| New | +$190K | 0.01% | 312 |
|
Other funds holding LRCX
Glenview Trust's LRCX Position: Q2 2026 in Review
Glenview Trust increased its Lam Research (LRCX) stake by 2% in Q2 2026, buying an estimated $605K and bringing the position to 100,253 shares worth $43.4M. The position accounts for 0.6% of the portfolio, ranked #38.
Glenview Trust first reported a position in LRCX in Q1 2019 and has held it in 29 quarters since. 3,118 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.
- Glenview Trust held 100,253 shares of Lam Research worth $43.4M as of Q2 2026.
- Glenview Trust bought 1,993 Lam Research shares in Q2 2026, an estimated $605K.
- Lam Research made up 0.6% of Glenview Trust's portfolio in Q2 2026, its #38 holding.
- Glenview Trust first reported a position in Lam Research in Q1 2019 and has held it in 29 quarters since.
- 3,118 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.
Based on Glenview Trust's 13F filing for Q2 2026, filed 11 Aug 2026.